Article info
Clinical and epidemiological research
Concise report
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial
- Correspondence to Dr David Jayne, Lupus and Vasculitis Clinic, Box 57, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK; dj106{at}cam.ac.uk
Citation
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial
Publication history
- Received August 3, 2014
- Revised January 19, 2015
- Accepted February 8, 2015
- First published March 4, 2015.
Online issue publication
February 12, 2020
Article Versions
- Previous version (12 February 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions